These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
199 related articles for article (PubMed ID: 12640506)
1. White-coat hypertension and normotension in the League of Hypertension of the Hospital das Clínicas, FMUSP: prevalence, clinical and demographic characteristics. Segre CA; Ueno RK; Warde KR; Accorsi TA; Miname MH; Chi CK; Pierin AM; Mion Júnior D Arq Bras Cardiol; 2003 Feb; 80(2):117-26. PubMed ID: 12640506 [TBL] [Abstract][Full Text] [Related]
2. Cardiac and arterial target organ damage in adults with elevated ambulatory and normal office blood pressure. Liu JE; Roman MJ; Pini R; Schwartz JE; Pickering TG; Devereux RB Ann Intern Med; 1999 Oct; 131(8):564-72. PubMed ID: 10523216 [TBL] [Abstract][Full Text] [Related]
4. Strategies for classifying patients based on office, home, and ambulatory blood pressure measurement. Zhang L; Li Y; Wei FF; Thijs L; Kang YY; Wang S; Xu TY; Wang JG; Staessen JA Hypertension; 2015 Jun; 65(6):1258-65. PubMed ID: 25870194 [TBL] [Abstract][Full Text] [Related]
5. [Arterial hypertension difficult to control in the elderly patient. The significance of the "white coat effect"]. Amado P; Vasconcelos N; Santos I; Almeida L; Nazaré J; Carmona J Rev Port Cardiol; 1999 Oct; 18(10):897-906. PubMed ID: 10590654 [TBL] [Abstract][Full Text] [Related]
6. Prevalence of masked uncontrolled and treated white-coat hypertension defined according to the average of morning and evening home blood pressure value: from the Japan Home versus Office Measurement Evaluation Study. Obara T; Ohkubo T; Kikuya M; Asayama K; Metoki H; Inoue R; Oikawa T; Komai R; Murai K; Horikawa T; Hashimoto J; Totsune K; Imai Y; Blood Press Monit; 2005 Dec; 10(6):311-6. PubMed ID: 16496446 [TBL] [Abstract][Full Text] [Related]
7. How often do office blood pressure measurements fail to identify true hypertension? An exploration of white-coat normotension. Selenta C; Hogan BE; Linden W Arch Fam Med; 2000 Jun; 9(6):533-40. PubMed ID: 10862216 [TBL] [Abstract][Full Text] [Related]
8. Lack of association between body-mass index and white-coat hypertension among referred patients. Ben-Dov IZ; Mekler J; Ben-Arie L; Bursztyn M Blood Press Monit; 2007 Apr; 12(2):95-9. PubMed ID: 17353652 [TBL] [Abstract][Full Text] [Related]
9. Prevalence of white coat hypertension in primary health care. Alves LM; Nogueira MS; Godoy Sd; Hayashida M; Cárnio EC Arq Bras Cardiol; 2007 Jul; 89(1):28-35. PubMed ID: 17768580 [TBL] [Abstract][Full Text] [Related]
10. Performance of the automated BpTRU measurement device in the assessment of white-coat hypertension and white-coat effect. Culleton BF; McKay DW; Campbell NR Blood Press Monit; 2006 Feb; 11(1):37-42. PubMed ID: 16410740 [TBL] [Abstract][Full Text] [Related]
11. [2013 Ambulatory blood pressure monitoring recommendations for the diagnosis of adult hypertension, assessment of cardiovascular and other hypertension-associated risk, and attainment of therapeutic goals (summary). Joint recommendations from the International Society for Chronobiology (ISC), American Association of Medical Chronobiology and Chronotherapeutics (AAMCC), Spanish Society of Applied Chronobiology, Chronotherapy, and Vascular Risk (SECAC), Spanish Society of Atherosclerosis (SEA), and Romanian Society of Internal Medicine (RSIM)]. Hermida RC; Smolensky MH; Ayala DE; Portaluppi F; Crespo JJ; Fabbian F; Haus E; Manfredini R; Mojón A; Moyá A; Piñeiro L; Ríos MT; Otero A; Balan H; Fernández JR Clin Investig Arterioscler; 2013; 25(2):74-82. PubMed ID: 23849214 [TBL] [Abstract][Full Text] [Related]
12. White coat hypertension in Zimbabwean African women. Bhagat K East Afr Med J; 2000 Aug; 77(8):452-5. PubMed ID: 12862073 [TBL] [Abstract][Full Text] [Related]
13. White coat hypertension diagnosed by 24-h ambulatory monitoring. Examination of 159 newly diagnosed hypertensive patients. Høegholm A; Kristensen KS; Madsen NH; Svendsen TL Am J Hypertens; 1992 Feb; 5(2):64-70. PubMed ID: 1550667 [TBL] [Abstract][Full Text] [Related]
14. "White coat hypertension" in type 2 diabetic patients. Ruxer J; Mozdzan M; Baranski M; Wozniak-Sosnowska U; Markuszewski L Pol Arch Med Wewn; 2007 Oct; 117(10):452-6. PubMed ID: 18320786 [TBL] [Abstract][Full Text] [Related]
15. White coat hypertension in early pregnancy in women with pre-existing diabetes: prevalence and pregnancy outcomes. Vestgaard M; Ásbjörnsdóttir B; Ringholm L; Andersen LLT; Jensen DM; Damm P; Mathiesen ER Diabetologia; 2019 Dec; 62(12):2188-2199. PubMed ID: 31628489 [TBL] [Abstract][Full Text] [Related]
16. White coat effect in treated hypertensive patients: sex differences. Myers MG; Reeves RA J Hum Hypertens; 1995 Sep; 9(9):729-33. PubMed ID: 8551486 [TBL] [Abstract][Full Text] [Related]
17. White coat hypertension and white coat effect. Similarities and differences. Verdecchia P; Schillaci G; Borgioni C; Ciucci A; Zampi I; Gattobigio R; Sacchi N; Porcellati C Am J Hypertens; 1995 Aug; 8(8):790-8. PubMed ID: 7576395 [TBL] [Abstract][Full Text] [Related]
18. Target organ damage in "white coat hypertension" and "masked hypertension". Kotsis V; Stabouli S; Toumanidis S; Papamichael C; Lekakis J; Germanidis G; Hatzitolios A; Rizos Z; Sion M; Zakopoulos N Am J Hypertens; 2008 Apr; 21(4):393-9. PubMed ID: 18292757 [TBL] [Abstract][Full Text] [Related]